Search for: "Myers, Appeal of" Results 81 - 100 of 1,399
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jan 2023, 3:17 pm by Matthew D. Kaplan
This incredibly complex case involved multiple defendants in separate jurisdictions and issues being appealed up through the Oregon Supreme Court. [read post]
31 Dec 2022, 3:12 pm by James Romoser
Dellinger was a longtime faculty member at Duke Law School, and he founded the appellate practice at O’Melveny & Myers. [read post]
25 Dec 2022, 2:14 am by Aaron L. Nielson
White, decided by the Court of Appeals for the District of Columbia (which eventually became the D.C. [read post]
10 Oct 2022, 9:07 am by Whittel & Melton, LLC
As the policy holder, you have the right to file an internal appeal, which means you can request another insurance adjuster to review the initial decision with fresh eyes. [read post]
3 Oct 2022, 2:20 pm by John McFarland
Last June the Corpus Christi Court of Appeals decided that the right to store oil in a salt cavern belongs to the surface owner. [read post]
14 Sep 2022, 4:47 am by Emma Snell
Steven Lee Myers reports for the New York Times. [read post]
9 Sep 2022, 4:00 am by Jim Sedor
National/Federal ‘Fat Leonard’ Goes on the Lam Weeks Before Sentencing in Navy Bribery Scandal Portland Press Herald – María Luisa Paúl (Washington Post) | Published: 9/6/2022 The Malaysian defense contractor who pleaded guilty to bribing Navy officials with sex parties, fancy dinners, and alcohol in a corruption scandal has escaped just weeks before his sentencing date. [read post]
1 Sep 2022, 1:25 pm by Unreported Opinions
Administrative law — Public works contract — Acceleration claim We are presented with two consolidated appeals relating to a contract dispute between a contractor, Allan Myers MD, Inc. [read post]
18 Aug 2022, 12:26 pm by Josh Blackman
Our duty is to resolve the appeal correctly and offer our independent explanation of the bases for our decision. [read post]
19 Jul 2022, 2:59 pm by Kevin LaCroix
In the following guest post, the authors revisit the question of whether or not securities class action lawsuits against development-stage biotech companies are likelier to survive a motion to dismiss compared to securities suits against other kinds of companies. [read post]